United Asset Strategies, Inc. Bio Rad Laboratories, Inc. Transaction History

United Asset Strategies, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$657.71 - $825.77 $328,855 - $412,885	-500 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$576.64 - $649.04 $57,664 - $64,904	-100 Reduced 16.67%	500 $322,000
Q1 2021 Apr 27, 2021	SELL	$547.01 - $662.35 $71,111 - $86,105	-130 Reduced 17.81%	600 $343,000
Q1 2020 May 08, 2020	SELL	$320.01 - $409.07 $38,401 - $49,088	-120 Reduced 14.12%	730 $256,000
Q2 2019 Jul 31, 2019	SELL	$286.93 - $312.59 $143,465 - $156,295	-500 Reduced 37.04%	850 $266,000
Q1 2019 May 02, 2019	SELL	$224.3 - $317.41 $11,215 - $15,870	-50 Reduced 3.57%	1,350 $413,000
Q3 2018 Nov 07, 2018	SELL	$289.28 - $326.15 $7,231 - $8,153	-25 Reduced 1.75%	1,400 $438,000
Q4 2017 Feb 09, 2018	BUY	$216.94 - $271.3 $309,139 - $386,602	1,425	1,425 $340,000

457

18.3M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on United Asset Strategies, Inc. with notifications on news.